Bio-Techne Corp (TECH)
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.
TECH SEC Filing Email Alerts Service
| Company Name: |
Bio-Techne Corp |
| Stock buyback: |
TECH buyback |
| Website: |
www.bio-techne.com |
| Sector: |
Biotechnology |
| Number of ETFs Holding TECH: |
89 |
| Total Market Value Held by ETFs: |
$1.89B |
| Total Market Capitalization: |
$9.94B |
| % of Market Cap. Held by ETFs: |
19.04% |
|
|
May 2, 2024 • 11:00 AM Eastern
Strong Buy (3.71 out of 4)
68th percentile
|
|
Free TECH Email Alerts:
